ArdorComm Media Group

Contact Us
Sunday, July 6, 2025 12:54 AM
logo
Menu
logo

COVID-19

No Proven Link Between COVID-19 Vaccines and Sudden Deaths, Confirms Union Health Ministry

Leave a Comment / / Health & Wellness Community

The Union Ministry of Health and Family Welfare has clarified that there is no scientific evidence connecting COVID-19 vaccination with sudden or unexplained deaths in India. This conclusion is backed by comprehensive studies conducted by the Indian Council of Medical Research (ICMR) and the National Centre for Disease Control (NCDC). In an official statement, the Ministry emphasized that extensive investigations were carried out across the country by multiple research agencies to examine reports of sudden deaths, particularly among seemingly healthy young adults. Findings from these studies have consistently shown no direct association between COVID-19 vaccines and such fatalities. Two key studies have been pivotal in reaching this conclusion. The first, undertaken by ICMR’s National Institute of Epidemiology (NIE), is a multicentric matched case-control study titled “Factors associated with unexplained sudden deaths among adults aged 18–45 years in India.” Conducted across 47 tertiary hospitals in 19 states and union territories from May to August 2023, the research analyzed cases between October 2021 and March 2023. The outcome was clear: COVID-19 vaccination does not increase the risk of sudden death in young, otherwise healthy adults. The second study, still in progress, is being led by AIIMS, New Delhi, with ICMR’s collaboration and support. This prospective research—“Establishing the cause in sudden unexplained deaths in young”—aims to pinpoint the most common reasons behind such fatalities. Preliminary data reveals that heart attacks (myocardial infarctions) remain the leading cause of sudden death in this demographic, with no significant shift in trends compared to previous years. In many cases, genetic factors have also emerged as likely contributors. These studies offer valuable insights into sudden deaths among young individuals and provide reassurance about the safety of COVID-19 vaccines. Researchers highlight that deaths may stem from a range of issues, including underlying health conditions, genetic predispositions, and unhealthy lifestyles, rather than vaccination. Public health experts have strongly criticized unverified claims linking vaccines to sudden deaths, calling them unscientific and dangerous. Such misinformation not only lacks factual basis but also poses a serious risk to public trust and could foster vaccine hesitancy, undermining one of the most effective tools used during the pandemic to save lives. The government reaffirmed its commitment to science-driven public health policies and continued research to safeguard the health and well-being of all citizens. Source: ANI

No Proven Link Between COVID-19 Vaccines and Sudden Deaths, Confirms Union Health Ministry Read More »

India Sees Uptick in COVID-19 Cases: Active Infections Near 4,000, Deaths Reported Across Key States

Leave a Comment / / Health & Wellness Community
Ardorcomm news

India is witnessing a steady rise in COVID-19 infections, with active cases reaching 3,961 as of Monday, June 2—a jump of 566 cases from the previous day, according to data from the Ministry of Health and Family Welfare (MoHFW). The recent surge is driven primarily by states like Kerala, Maharashtra, and Delhi, which are reporting the highest case numbers. Since the start of the year, the country has registered 32 COVID-related deaths, including four in the last 24 hours. One fatality each was reported from Delhi, Kerala, Maharashtra, and Tamil Nadu. The deceased include a 22-year-old woman from Delhi with a history of post-tuberculosis complications and a 44-year-old man from Maharashtra suffering from acute respiratory distress and aortic valve problems. While Kerala confirmed another death, specific details are awaited. Delhi Records Steepest Daily Spike; Tamil Nadu, Karnataka Also Report Fatalities Delhi saw the most significant daily rise in active infections among major states, adding 47 new cases and logging one death. Tamil Nadu, with 189 active cases, reported the passing of a 25-year-old man with underlying bronchial asthma and acute kidney complications. Karnataka, currently reporting 253 active cases, recorded a fresh fatality, while Uttar Pradesh reported two deaths and has 157 active cases. In total, 16 states and Union Territories have recorded COVID-related deaths in 2025. However, the majority of cases remain mild, with limited hospital admissions. Kerala Leads in Caseload; Maharashtra, West Bengal Also on High Alert Kerala continues to report the highest number of active COVID-19 cases at 1,435, rising from 1,336 the previous day. Maharashtra follows with 506 active cases, and Delhi with 483. West Bengal has also seen a surge, reporting 331 active infections. Other notable figures include: Gujarat: 338 Karnataka: 253 Tamil Nadu: 189 Uttar Pradesh: 157 Rajasthan: 69 States like Madhya Pradesh (23), Haryana (28), and Odisha (12) have recorded smaller increases. In the last 24 hours, 203 patients have recovered, pushing the total number of recoveries and migrations this year to 2,188. Authorities Urge Caution, Not Panic Health experts and officials maintain that the situation is under control, emphasizing that most new cases are mild and manageable at home. Dr. Rajiv Behl, Director General of the Indian Council of Medical Research (ICMR), reassured the public that while increased vigilance is necessary, there’s no immediate cause for alarm. The rise in cases coincides with the detection of new Omicron sub-variants—LF.7, XFG, JN.1, and NB.1.8.1—identified in genome sequencing studies from western and southern India. These have been classified by the World Health Organization as “Variants Under Monitoring,” indicating they don’t currently pose a significant global threat. Preparedness Measures in Place as Precaution In response, state health departments—particularly in Delhi, Maharashtra, and Kerala—are ramping up hospital readiness and reviewing medical supply logistics. Citizens, especially vulnerable groups such as the elderly and those with pre-existing health issues, are being encouraged to wear masks in crowded or poorly ventilated settings. Experts stress that while the virus is spreading faster due to more contagious but less severe sub-variants, preventive strategies such as timely testing, vaccination, and community awareness remain key to containing its impact. Though the overall caseload is still far lower than during peak waves, the recent tenfold increase over two weeks underscores the need for continued monitoring, public cooperation, and proactive measures to avoid another significant outbreak. Source: Economic Times Photo Credit: iStock   

India Sees Uptick in COVID-19 Cases: Active Infections Near 4,000, Deaths Reported Across Key States Read More »

Highly Contagious COVID-19 Variant NB.1.8.1 Spreads from China to the US

Leave a Comment / / Uncategorized
Ardorcomm news

A newly emerging COVID-19 variant, NB.1.8.1 — known for its high transmissibility and recent surge in China — has now been identified in the United States, including cases in New York City, according to the Centers for Disease Control and Prevention (CDC). The variant was first detected among international travelers entering the U.S. between late March and early April through airports in California, Washington State, Virginia, and New York. Since then, additional infections have been reported in Ohio, Rhode Island, and Hawaii. Although the U.S. case count remains relatively small, public health experts are monitoring the situation closely due to the variant’s rapid spread across Asia, where it has become the leading strain. In Hong Kong, the NB.1.8.1 variant has led to a significant rise in hospital admissions and emergency visits, particularly affecting senior citizens. Reports indicate that within a span of four weeks, the city recorded 81 severe cases and 30 fatalities, primarily among individuals aged 65 and older. Mainland China has also seen a steep increase in COVID-positive patients in emergency departments, along with a spike in hospitalizations. However, Chinese health authorities maintain that the variant does not pose a greater threat than earlier strains. U.S. experts are taking a more cautious stance. Dr. Amy Edwards of Case Western Reserve University noted that while NB.1.8.1 may not result in more severe illness, its rapid transmission is concerning. “There’s a clear increase in hospital activity in places like China and Hong Kong,” she told CBS News. CDC data shows that those carrying the variant had traveled from countries including China, Japan, South Korea, Vietnam, Thailand, France, Spain, and Taiwan — suggesting broader international transmission. NB.1.8.1 presents symptoms similar to prior variants — including fatigue, fever, sore throat, and coughing — but scientists believe it has a “growth advantage,” potentially allowing it to spread more efficiently. Dr. Subhash Verma from the University of Nevada highlighted this increased transmissibility as a cause for concern. In Hong Kong, Dr. Edwin Tsui of the Centre for Health Protection urged vigilance, warning that the variant might be more adept at bypassing existing vaccine defenses. Health officials there are tracking the variant’s evolution in line with World Health Organization (WHO) guidance. The emergence of NB.1.8.1 coincides with changes to U.S. COVID-19 vaccine policy. The CDC recently updated its guidelines, advising against routine vaccination for healthy children and pregnant women. Future booster shots will primarily target high-risk populations, such as the elderly and immunocompromised individuals. Source: NDTV Photo Credit: Reuters

Highly Contagious COVID-19 Variant NB.1.8.1 Spreads from China to the US Read More »

New COVID-19 Subvariants NB.1.8.1 and LF.7 Detected in India: INSACOG Report

Leave a Comment / / Health & Wellness Community

India has recorded the presence of two newly emerging COVID-19 subvariants—NB.1.8.1 and LF.7—according to recent data released by the Indian SARS-CoV-2 Genomics Consortium (INSACOG). While these variants are currently categorized as Variants Under Monitoring by the World Health Organization (WHO), they have been linked to the recent surge in COVID-19 cases across China and parts of Asia. As per the INSACOG data, a single case of NB.1.8.1 was identified in Tamil Nadu in April, while four cases of LF.7 were reported from Gujarat in May 2025. Despite these new detections, the dominant strain circulating in India remains JN.1, accounting for approximately 53% of the tested samples. It is followed by BA.2 (26%) and other Omicron-related variants (20%). Preliminary assessments by WHO suggest that NB.1.8.1 poses a low global public health risk, but the subvariant carries spike protein mutations—A435S, V445H, and T478I—that may enhance both transmissibility and the ability to evade immune responses. As of May 19, India reported 257 active COVID-19 cases. A high-level review meeting was recently convened, chaired by the Director General of Health Services, with participation from the ICMR, National Centre for Disease Control, and other leading health agencies to monitor the evolving situation. Meanwhile, certain states have shown localized spikes. Delhi reported 23 new cases, Andhra Pradesh had four, Telangana confirmed one, and Bengaluru recorded a positive case in a nine-month-old infant, reflecting a steady rise over the last 20 days. Kerala, in particular, reported 273 cases in May alone. Source: PTI

New COVID-19 Subvariants NB.1.8.1 and LF.7 Detected in India: INSACOG Report Read More »

India Became ‘Pharmacy of the World’ During Covid-19: JP Nadda

Leave a Comment / / Health & Wellness Community
ArdorComm news

Union Minister of Health and Family Welfare, JP Nadda, hailed India as the ‘Pharmacy of the World’ on Monday while emphasizing the country’s significant contributions to global healthcare during the Covid-19 pandemic. Nadda was speaking at the 19th International Conference of Drug Regulatory Authorities (ICDRA) in New Delhi, where leaders from over 120 countries gathered to discuss regulatory practices and collaborative solutions to enhance global healthcare standards. “This prestigious platform [19th ICDRA] reflects our shared commitment to enhancing global healthcare standards and safeguarding public health,” Nadda said. He highlighted India’s pivotal role in addressing global health challenges through innovation, resilience, and collaboration. India’s Covid-19 Response: Vaccine Production and Global Impact Nadda elaborated on India’s rapid response during the pandemic, particularly its ability to ramp up vaccine production to meet both domestic and international needs. “During the unprecedented Covid-19 pandemic, India emerged not only as a global leader in health resilience and innovation but also reaffirmed its role as the pharmacy of the world,” he said. India’s extensive vaccination campaign, which successfully inoculated over a billion people, was described as a major milestone. Nadda credited healthcare workers and government initiatives for ensuring affordable access to essential medicines, vaccines, and medical supplies for nations around the globe. He also underscored India’s assistance to over 150 countries during the pandemic, driven by the ethos of “Vasudhaiva Kutumbakam,” the ancient Indian philosophy that emphasizes “the world is one family.” Cross-Border Collaboration and Regulatory Advancements Nadda emphasized that cross-border collaboration is essential for addressing global healthcare challenges. “The theme of this conference resonates deeply with our core belief that collaboration across borders, sectors, and disciplines is essential for creating lasting health solutions,” he stated. He also outlined India’s efforts to modernize its regulatory framework, highlighting the establishment of eight operational drug testing laboratories, with two more in the pipeline. Furthermore, eight mini testing labs have been set up at various ports to expedite the testing of imported materials. Over 95 percent of regulatory processes in India have been digitized, and the country’s medical device industry is now under regulation. With India’s healthcare system playing a crucial role in ensuring affordable access to medical supplies and vaccines during the pandemic, Nadda emphasized the importance of continued innovation and global cooperation to build a healthier, more resilient world. Source: Business Standard

India Became ‘Pharmacy of the World’ During Covid-19: JP Nadda Read More »

EU Initiates Complaints Against Microsoft’s 365 Education Suite Over Privacy Concern

Leave a Comment / / Education Community

Microsoft is currently facing two complaints in the European Union (EU) regarding its online education software, 365 Education. According to a report by Reuters, the latest charges against the US-based tech giant have been brought to the Austrian privacy watchdog by the privacy advocacy group NOYB. The group has urged the Austrian Data Protection Authority to investigate these complaints and potentially impose a fine on Microsoft. What is Microsoft 365 Education Suite? During the COVID-19 pandemic, online educational programs gained popularity as schools transitioned to remote teaching. Microsoft’s 365 Education suite offers various tools for students, including Word, Excel, Microsoft Teams, PowerPoint, and Outlook. Complaints Against Microsoft’s 365 Education Suite First Complaint: The advocacy group NOYB alleged that Microsoft shifted the burden of complying with EU data privacy laws (GDPR) onto schools. According to NOYB, schools cannot adequately manage student data under these regulations. NOYB lawyer Maartje de Graaf stated: “Under the current system that Microsoft is imposing on schools, your school would have to audit Microsoft or give them instructions on how to process pupils’ data. Everyone knows that such contractual arrangements are out of touch with reality. This is nothing more but an attempt to shift the responsibility for children’s data as far away from Microsoft as possible.” Second Complaint: The second complaint centers around cookies installed in Microsoft’s 365 Education suite that advertisers use to track consumers. NOYB lawyer Felix Mikolasch expressed concerns: “Our analysis of the data flows is very worrying. Microsoft 365 Education appears to track users regardless of their age. This practice is likely to affect hundreds of thousands of pupils and students in the EU and EEA (European Economic Area).” EU’s Previous Warnings to Microsoft Last month, the EU warned Microsoft that it could impose a fine of up to 1% of its global annual revenue if it fails to provide requested information about the risks associated with its generative AI tools in the Bing search engine. In March, the EU asked tech giants, including Microsoft, to provide details on how they manage risks from AI tools. Microsoft has been accused of dodging questions about its “Copilot in Bing” and “Image Creator” features, which the EU fears may violate new laws by spreading misinformation and manipulating voters.  

EU Initiates Complaints Against Microsoft’s 365 Education Suite Over Privacy Concern Read More »

Saudi Arabia Reports Three New MERS Cases, Highlighting Risks and Differences from COVID-19

Leave a Comment / / Health & Wellness Community

The Saudi health ministry has notified the World Health Organization (WHO) of three new Middle East Respiratory Syndrome (MERS) coronavirus cases in Riyadh, Saudi Arabia. Sadly, one of these cases resulted in death. All three individuals were male, aged between 56 and 60, with pre-existing health conditions. None of them were healthcare workers. This brings the total number of MERS cases reported in Saudi Arabia in 2024 to four, with two fatalities. Dr. Syed Abdul Aleem, a Pulmonology Consultant at CARE Hospitals in Musheerabad, Hyderabad, explains that MERS-CoV is a viral respiratory illness caused by the MERS strain of coronavirus. Unlike COVID-19, MERS tends to be more severe with a higher mortality rate but is less contagious. It is primarily transmitted from camels to humans, with limited human-to-human transmission. Risk factors for MERS-CoV include close contact with camels or living in endemic regions, along with underlying medical conditions such as diabetes or chronic lung disease. Symptoms are similar to COVID-19, including fever, cough, and shortness of breath, but MERS can progress to severe respiratory illness, leading to pneumonia and acute respiratory distress syndrome (ARDS). Some individuals may also experience gastrointestinal symptoms like diarrhea. Management involves supportive care, with severe cases requiring hospitalization and supportive measures like supplemental oxygen therapy and mechanical ventilation. There is no specific antiviral treatment for MERS, but prevention measures include avoiding close contact with camels, practicing good hand hygiene, and avoiding contact with sick individuals. This highlights the importance of understanding the differences between MERS and COVID-19 and taking appropriate precautions to prevent transmission and manage cases effectively.  

Saudi Arabia Reports Three New MERS Cases, Highlighting Risks and Differences from COVID-19 Read More »

The Economic Wisdom of an Annual COVID-19 Vaccine: A Comprehensive Study

Leave a Comment / / Blogs
Blog on Health

The COVID-19 pandemic has reshaped our lives in profound ways, influencing everything from our daily routines to global economies. As vaccination rates wane and governments reconsider their policies, questions arise regarding the necessity and benefits of an annual COVID-19 vaccine. A recent study published in The Journal of Infectious Diseases sheds light on this issue, exploring the economic and clinical advantages of an annual COVID-19 vaccination from an individual perspective. The study’s findings underscore the importance of ongoing vaccination efforts in mitigating the impact of COVID-19 on both personal health and finances. Despite decreasing morbidity and mortality rates, the economic value of annual vaccination remains significant, particularly for adults aged 18 to 64. The research employs a sophisticated Markov computational simulation model to assess the economic implications of annual COVID-19 vaccination, considering factors such as infection risk, clinical outcomes, and vaccine efficacy. Key findings from the study reveal that individuals, regardless of health insurance status, stand to benefit clinically and economically from annual COVID-19 vaccination. Notably, adults aged 50 to 64 experience the highest economic savings, emphasizing the importance of continued vaccination efforts among older populations. The study’s comprehensive approach provides valuable insights into the cost-benefit dynamics of annual COVID-19 vaccination, informing individual decision-making in an evolving pandemic landscape. As the world navigates the ongoing challenges of the COVID-19 pandemic, evidence-based research remains crucial in guiding public health policies and individual behaviors. The study’s implications extend beyond the realm of healthcare, highlighting the interconnectedness of health and economics in shaping societal well-being. By investing in annual COVID-19 vaccination, individuals can safeguard their health while making prudent financial decisions, contributing to a safer and more resilient future for all. In conclusion, the study underscores the wisdom of investing in an annual COVID-19 vaccine, both for personal health and economic prosperity. As governments and individuals alike consider the path forward in a post-pandemic world, the findings serve as a timely reminder of the enduring value of vaccination in protecting lives and livelihoods.  

The Economic Wisdom of an Annual COVID-19 Vaccine: A Comprehensive Study Read More »

Zell Education Launches Global Career Championship, Offering Financial Education Scholarships

Leave a Comment / / Education Community

Zell Education has unveiled the Global Career Championship, a scholarship program designed to empower students and professionals seeking to enhance their skills in finance and accounts. The initiative aims to provide a platform for individuals globally to upskill, fostering career growth in the competitive field of financial education. In a recent press release, Zell Education highlighted the program’s focus on offering opportunities for students and working professionals worldwide. The Global Career Championship invites participants to showcase their expertise and passion for finance, with the winner earning exclusive access to Zell Education’s advanced courses. The scholarship covers a spectrum of finance-related subjects, including ACCA, FRM, CFA, CMA, IFRS, and other finance and accounts courses. Notably, the winner will enjoy complimentary enrollment in these courses, with all associated global body fees and coaching fees fully covered. Pratham Barot, CEO and Co-Founder of Zell Education, expressed enthusiasm about the Global Career Championship, emphasizing its role in helping individuals acquire the necessary expertise to excel in their careers. Barot stated, “The Global Career Championship is our way of helping ambitious learners with the knowledge and resources they require to succeed.” This initiative underscores Zell Education’s commitment to fostering learning and development in the field of finance, providing a unique opportunity for individuals globally to advance their careers through top-notch educational offerings. Aspiring candidates eager to excel in finance and accounts are encouraged to participate in the Global Career Championship and leverage this scholarship program for professional growth.

Zell Education Launches Global Career Championship, Offering Financial Education Scholarships Read More »

Chinese Health Authorities Warn of Potential COVID-19 Rebound in January

Leave a Comment / / Health & Wellness Community

Chinese health authorities have issued a warning of a possible rebound in COVID-19 infections in January, despite a recent decline in patients at fever clinics since New Year’s Day. The National Health Commission spokesperson, Mi Feng, stated at a press briefing that while respiratory diseases, mainly influenza, are still prevalent, the COVID-19 infection rate remains relatively low. Recent data from the multi-channel monitoring system revealed a positive rate of COVID-19 testing below one percent in sentinel hospitals after the New Year’s Day holiday. Wang Dayan, director of the China National Influenza Center, expressed concern about the upward trend in the proportion of the JN.1 variant strain, indicating a potential resurgence. Experts anticipate a co-circulation of respiratory pathogens during the winter and spring, with influenza viruses dominating in the short term. Wang Dayan highlighted the potential for a COVID-19 rebound in January due to the continuous importation of the JN.1 variant, declining influenza, and a decrease in population immunity. The JN.1 variant is likely to become the dominant strain in China. Influenza B virus proportions have risen significantly in both southern and northern provinces, surpassing influenza A in some regions. Wang emphasized the need for early influenza vaccination, as the immune response from contracting influenza A does not protect against influenza B. Wang Guiqiang, director of the Department of Infectious Diseases at Peking University First Hospital, emphasized the peak season for respiratory infectious diseases in winter and the potential for repeated infections. He urged increased attention to early intervention and diagnosis, particularly for the elderly and those with underlying diseases, as COVID-19 or influenza infections could worsen underlying conditions.

Chinese Health Authorities Warn of Potential COVID-19 Rebound in January Read More »